MSB 4.08% $1.02 mesoblast limited

The good old Madam ! As noted - in my opinion. Point is - you...

  1. 384 Posts.
    lightbulb Created with Sketch. 5
    The good old Madam !
    As noted - in my opinion.

    Point is - you say the Teva R/ship is dubious...fair enough as well because like me its your opinion.

    However I say Teva R/ship is solid and thick (based on CEO comments and analyst notes).
    And from my point of view, I also say it would make logical sense that the r/ship could be further enhanced with the following announcements:

    19/3/2015:
    MESOBLAST SELECTED FOR FAST TRACK ACCESS TO POTENTIAL INVESTMENT INCENTIVES IN JAPAN ; and

    27/3/2015:

    MESOBLAST KEY PATENT ALLOWED IN JAPAN FOR THE TREATMENT OF HEART DISEASES, STROKE, AND OTHER VASCULAR CONDITIONS

    Teva have a good presence in Japan and with the support of JETRO - why wouldn't any commercially driven Pharma look to take advantage of the "new" Regenerative Medicine laws in Japan – particularly when there are potentiall significant incentives.

    Madam – do you see any negatives in the above 2 announcements ?


    DYOR. Above just in my opinion.
    GLTAH - 2015

 
watchlist Created with Sketch. Add MSB (ASX) to my watchlist
(20min delay)
Last
$1.02
Change
0.040(4.08%)
Mkt cap ! $1.118B
Open High Low Value Volume
$1.01 $1.04 99.0¢ $1.743M 1.708M

Buyers (Bids)

No. Vol. Price($)
7 34448 $1.02
 

Sellers (Offers)

Price($) Vol. No.
$1.03 20058 20
View Market Depth
Last trade - 10.35am 16/08/2024 (20 minute delay) ?
MSB (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.